Prognostic factors for competing risk in patients with AIDS-related Kaposi's sarcoma: A SEER population-based study

被引:2
作者
Wang, Haili [1 ]
Guo, Chengnan [2 ]
Zhang, Xin [1 ]
Xu, Yiyun [1 ]
Li, Yi [1 ]
Wang, Tianye [1 ]
Liu, Zhenqiu [3 ,4 ]
Zhu, Xiaohua [5 ]
Zhang, Tiejun [1 ,2 ,6 ,7 ]
机构
[1] Fudan Univ, Sch Publ Hlth, Dept Epidemiol, Shanghai, Peoples R China
[2] Fudan Univ, Shanghai Inst Infect Dis & Biosecur, Shanghai, Peoples R China
[3] Fudan Univ, Human Phenome Inst, State Key Lab Genet Engn, Shanghai, Peoples R China
[4] Fudan Univ, Sch Life Sci, Shanghai, Peoples R China
[5] Fudan Univ, Huashan Hosp, Dept Dermatol, Shanghai 200040, Peoples R China
[6] Fudan Univ, Yiwu Res Institue, Yiwu, Peoples R China
[7] Fudan Univ, Sch Publ Hlth, Shanghai 200032, Peoples R China
关键词
AIDS-Kaposi's sarcoma; cancer-specific mortality; competing risk; nomogram; SEER; CANCER INCIDENCE; MARITAL-STATUS; SURVIVAL-DATA; COHORT; HAART; DISPARITIES; DIAGNOSIS; HIV/AIDS; PATTERNS; TRENDS;
D O I
10.1111/hiv.13530
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Objectives: Despite the improved survival of patients with AIDS and Kaposi's sarcoma (KS), competing events are a non-negligible issue affecting the survival of such patients. In this study, we explored the prognostic factors of KS-specific and non-KS-specific mortality in patients with AIDS-related KS (AIDS-KS), accounting for competing risk.Methods: We identified 17 103 patients with AIDS-KS aged 18-65 years between 1980 and 2016 from the Surveillance, Epidemiology, and End Results (SEER) 18 registry database. Prognostic factors for KS-specific and non-KS-specific mortality were determined by the Fine and Grey proportional subdistribution hazard model. We built competing risk nomograms and assessed their predictive performance based on the identified prognostic factors.Results: In total, 12 943 (75.68%) patients died, 1965 (15.50%) of whom died from competing events. The KS-specific mortality rate was 14 835 per 100 000 person-years, and the non-KS specific mortality rate was 2719 per 100 000 person-years. Specifically, age >44 years was associated with an 11% decrease in the subdistribution hazard of KS-specific mortality compared with age <43 years but a 50% increase in the subdistribution hazard of non-KS-specific mortality. Being male was associated with a 26% increase in the subdistribution hazard of KS-specific mortality compared with being female but a 32% decrease in the subdistribution hazard of non-KS-specific mortality. Notably, being in the antiretroviral therapy (ART) era consistently showed a decrease in the subdistribution hazard of both KS-specific and non-KS-specific mortality than being in the pre-ART era.Conclusions: Competing events commonly occurred among patients with AIDS-KS, which deserves further attention to improve the prognosis of these patients.
引用
收藏
页码:60 / 71
页数:12
相关论文
共 48 条
[1]   United States burden of melanoma and non-melanoma skin cancer from 1990 to 2019 [J].
Aggarwal, Pushkar ;
Knabel, Peter ;
Fleischer, Alan B., Jr. .
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2021, 85 (02) :388-395
[2]   Marital Status and Survival in Patients With Cancer [J].
Aizer, Ayal A. ;
Chen, Ming-Hui ;
McCarthy, Ellen P. ;
Mendu, Mallika L. ;
Koo, Sophia ;
Wilhite, Tyler J. ;
Graham, Powell L. ;
Choueiri, Toni K. ;
Hoffman, Karen E. ;
Martin, Neil E. ;
Hu, Jim C. ;
Nguyen, Paul L. .
JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (31) :3869-3876
[3]   Predictors of mortality among adolescents and young adults living with HIV on antiretroviral therapy in Dar es Salaam, Tanzania: a retrospective cohort study [J].
Amour, Maryam A. ;
Shayo, Grace A. ;
Matee, Mecky M. ;
Machumi, Lameck ;
Rugarabamu, Angelica ;
Aris, Eric A. ;
Sunguya, Bruno F. ;
Mugusi, Ferdinand M. .
JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 2022, 25 (02)
[4]   Epidemiology of classic and AIDS-related Kaposi's sarcoma in the USA: incidence, survival, and geographical distribution from 1975 to 2005 [J].
Armstrong, A. W. ;
Lam, K. H. ;
Chase, E. P. .
EPIDEMIOLOGY AND INFECTION, 2013, 141 (01) :200-206
[5]   Association of Multiple Primary Skin Cancers With Human Immunodeficiency Virus Infection, CD4 Count, and Viral Load [J].
Asgari, Maryam M. ;
Ray, G. Thomas ;
Quesenberry, Charles P., Jr. ;
Katz, Kenneth A. ;
Silverberg, Michael J. .
JAMA DERMATOLOGY, 2017, 153 (09) :892-896
[6]   Practical recommendations for reporting Fine-Gray model analyses for competing risk data [J].
Austin, Peter C. ;
Fine, Jason P. .
STATISTICS IN MEDICINE, 2017, 36 (27) :4391-4400
[7]   Introduction to the Analysis of Survival Data in the Presence of Competing Risks [J].
Austin, Peter C. ;
Lee, Douglas S. ;
Fine, Jason P. .
CIRCULATION, 2016, 133 (06) :601-609
[8]   Nomograms in oncology: more than meets the eye [J].
Balachandran, Vinod P. ;
Gonen, Mithat ;
Smith, J. Joshua ;
DeMatteo, Ronald P. .
LANCET ONCOLOGY, 2015, 16 (04) :E173-E180
[9]   RISK OF OTHER CANCERS FOLLOWING KAPOSIS-SARCOMA - RELATION TO ACQUIRED-IMMUNODEFICIENCY-SYNDROME [J].
BIGGAR, RJ ;
CURTIS, RE ;
COTE, TR ;
RABKIN, CS ;
MELBYE, M .
AMERICAN JOURNAL OF EPIDEMIOLOGY, 1994, 139 (04) :362-368
[10]   Prospective Stage-Stratified Approach to AIDS-Related Kaposi's Sarcoma [J].
Bower, Mark ;
Dalla Pria, Alessia ;
Coyle, Chris ;
Andrews, Eileen ;
Tittle, Victoria ;
Dhoot, Sharanjit ;
Nelson, Mark .
JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (05) :409-414